Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Oncology

85P: Performance of EBUS-TBNA in NSCLC Mediastinal Staging Stratified According to ACCP Radiographic Groups on CT

Journal of Thoracic Oncology

English

JCSE01.17 Weekly Nab-Paclitaxel Plus Carboplatin as Neoadjuvant Therapy for IIIA-N2 Lung Squamous Cell Carcinoma: A Prospective Phase II Study

Journal of Thoracic Oncology

English

MA04.09 Neoadjuvant Atezolizumab in Resectable Non-Small Cell Lung Cancer (NSCLC): Updated Results From a Multicenter Study (LCMC3)

Journal of Thoracic Oncology

English

MA13.10 Comparison of Pulmonary Nodule Location Between Preprocedural CT and Intra-Procedural Cone-Beam CT During Guided Bronchoscopy

Journal of Thoracic Oncology

English

MA18.03 How in the Real World Are Lung Cancer Patients Treated? The Ontario, Canada Experience

Journal of Thoracic Oncology

English

P1.09-32 Classification and Mutation Prediction From Non-Small Cell Lung Cancer Histopathology Images Using Deep Learning

Journal of Thoracic Oncology

English

Variable Response to ALK Inhibitors in NSCLC With a Novel MYT1L-ALK Fusion

Journal of Thoracic Oncology

English

P2.01-88 C-Reactive Protein (CRP) as a Predictive Marker for Survival in Patients With Advanced NSCLC Treated With First Line Pembrolizumab Monotherapy

Journal of Thoracic Oncology

English

P2.01-93 the Analysis of the Soluble Programmed Death-1 of Lung Cancer Patients With Different Characteristics

Journal of Thoracic Oncology

English

MA24.06 Long Non-Coding Rna Expression Patterns Delineate Infiltrating Immune Cells in the Lung Tumour Microenvironment

Journal of Thoracic Oncology

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Oncology

85P: Performance of EBUS-TBNA in NSCLC Mediastinal Staging Stratified According to ACCP Radiographic Groups on CT

JCSE01.17 Weekly Nab-Paclitaxel Plus Carboplatin as Neoadjuvant Therapy for IIIA-N2 Lung Squamous Cell Carcinoma: A Prospective Phase II Study

MA04.09 Neoadjuvant Atezolizumab in Resectable Non-Small Cell Lung Cancer (NSCLC): Updated Results From a Multicenter Study (LCMC3)

MA13.10 Comparison of Pulmonary Nodule Location Between Preprocedural CT and Intra-Procedural Cone-Beam CT During Guided Bronchoscopy

MA18.03 How in the Real World Are Lung Cancer Patients Treated? The Ontario, Canada Experience

P1.09-32 Classification and Mutation Prediction From Non-Small Cell Lung Cancer Histopathology Images Using Deep Learning

Variable Response to ALK Inhibitors in NSCLC With a Novel MYT1L-ALK Fusion

P2.01-88 C-Reactive Protein (CRP) as a Predictive Marker for Survival in Patients With Advanced NSCLC Treated With First Line Pembrolizumab Monotherapy

P2.01-93 the Analysis of the Soluble Programmed Death-1 of Lung Cancer Patients With Different Characteristics

MA24.06 Long Non-Coding Rna Expression Patterns Delineate Infiltrating Immune Cells in the Lung Tumour Microenvironment